Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Judicial Advocacy
    • Know Your Rights
    • New York Step Therapy Reform
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Responds to HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

0
By Aimed Alliance on July 17, 2018 Aimed Activity, Comments & Sign-on Letters, Drug Pricing, Drug Pricing: Policy Activity, Policymakers, Resources

Aimed Alliance Responds to HHS’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. Read here.

Last Updated on May 13, 2020 by Aimed Alliance

Advocacy FDA Federal Medicare Pharmacy Benefit Managers Rebates Transparency
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • December 8, 2025

    Trump Administration Must Address the Use of Junk Science

  • November 28, 2025

    Aimed Alliance Publishes New Resource on the USTR and MFN

  • November 25, 2025

    CMS Launches GENEROUS Model to Lower Medicaid Drug Costs and Expand Access 

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube